Moreover, targeted anti-eosinophilic treatment with anti-IL5 antibody in children with moderate-to-severe asthma who had an increased EGFR/SMAD-related nasal epithelial/remodeling gene signature resulted in worsening exacerbations (59). This evidence concerns the gene EGFR and asthma.